The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +49 211 5424 4040
Fax +49 211 5424 4044

Deutschland: Gewerblicher Rechtsschutz

Marken- und Wettbewerbsrecht
Marken- und Wettbewerbsrecht - ranked: tier 5

Arnold Ruess Rechtsanwälte PartmbB

Das 'sehr kompetente' Team der Düsseldorfer IP-Boutique Arnold Ruess Rechtsanwälte PartmbB bietet einer nationalen und internationalen Mandantschaft ein vollumfängliches Beratungsangebot im Marken- und Wettbewerbsrecht. Die Praxis ruht überwiegend auf den Schultern von Gründungspartner Peter Ruess, zu dessen Highlights neben der umfassenden Vertretung von Sony Interactive Entertainment im Marken- und Designrecht auch die strategische Beratung des Bundesverbands Deutscher Tabakwaren-Großhändler und Automatenaufsteller zählte. Counsel Anja Doepner-Thiele ist für Dr. Kurt Wolff die Ansprechpartnerin für die laufende wettbewerbsrechtliche Beratung und kosmetik- und heilmittelwerberechtliche Fragen in streitigen Auseinandersetzungen. Weitere Mandate kamen von Guhl, dem Johanniterorden und De Zuivelstichting.

[von unten nach oben]

Patentrecht - Streitbeilegung
Patentrecht - Streitbeilegung - ranked: tier 2

Arnold Ruess Rechtsanwälte PartmbB

Arnold Ruess Rechtsanwälte PartmbB kombiniert 'hervorragenden Service' mit einem 'persönlichen Beratungsansatz' und einem 'Fokus auf die Qualität der Arbeit anstatt auf die abrechenbaren Kosten'. Die Düsseldorfer IP-Boutique zählt mit Namenspartner Bernhard Arnold, der für 'seinen ausgeprägten Geschäftssinn' und sein 'strategisches Denken' geschätzt wird, der 'klugen, kreativen und Gegnern gegenüber harten' Cordula Schumacher und dem Anfang 2018 ernannten Partner Arno Riße mittlerweile drei Partner. Zu den Dauerbrennern zählt neben der von Schumacher geleiteten Vertretung von Celltrion in einem Verfügungs- und Hauptsacheverfahren gegen Roche wegen eines Biosimilars auch die gemeinsam von Arnold und Riße durchgeführte Verteidigung von Edgewell gegen von Procter & Gamble eingereichte Patentverletzungsklagen betreffend Rasierklingen. Die Beratung der Ethical Coffee Company als Klägerin in gegen Nestlé geführten Verletzungsverfahren betreffend in Nespressomaschinen verwendete Patente sorgte ebenfalls weiter für Arbeit. Counsel Andreas Kramer wechselte im April 2018 zu Vossius & Partner; man konnte aber mit der im Oktober 2018 von PwC Legal (PricewaterhouseCoopers Legal AG Rechtsanwaltsgesellschaft) kommenden Dörthe Minde die Counselriege wieder stärken. Nokia, Estar Medical und Hexal sind ebenfalls Mandanten.

Führende Namen

Bernhard Arnold - Arnold Ruess Rechtsanwälte PartmbB

Namen der nächsten Generation

Arno Riße - Arnold Ruess Rechtsanwälte PartmbB

[von unten nach oben]

Weitere Informationen über Arnold Ruess Rechtsanwälte PartmbB

Bitte wählen Sie von der folgenden Liste, um unsere Kommentare zu Arnold Ruess Rechtsanwälte PartmbB anderen Jurisdiktionen zu betrachten.


Büros in Dusseldorf

Co-Publishing weltweit

Rechtsentwicklungen und Neuigkeiten der führenden Anwälte in verschiedenen Jurisdiktionen. Für Beitrüge schicken Sie bitte eine Anfrage per Email an
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Hong Kong: The evolving role of independent non-executive directors - May 2014

     In a recent speech given by Mr. Carlson Tong, Chairman of the Securities and Futures Commission, Mr. Tong pointed out that companies can improve corporate governance by attaching higher importance to the role of their board of directors as an internal gatekeeper. Mr. Tong said that this can be done more easily by having effective independent non-executive directors (INEDs) on the board.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Competition law developments in East Asia - May 2014

    Authorities in Hong Kong have taken further steps in their deliberate approach to enforcing the Competition Ordinance. A little over a year after it was appointed, the Competition Commission released a report in which it provides a brief introduction to the Ordinance as well as a roadmap leading to its full entry into force. The report also explains how the Commission will prioritise its enforcement activities, and identifies the guidelines, policies and compliance tools which it plans to release before the Ordinance is enforced. Currently only some of the institutional provisions of the Ordinance are effective, allowing the Commission and the Competition Tribunal to prepare for enforcement.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .
  • Walking a Tightrope in Singapore - July 2014

    The world has no borders and distance is negligible for the technologically savvy criminal. Individuals with illicit funds to launder or terrorist activities to finance can, with the latest technology, transfer high volumes of money around the globe almost instantaneously and seek to conceal the origin or the destination of the funds.
  • Indonesia banking bill: proposed restrictions on foreign investment - July 2014

    Indonesia's House of Representatives is currently considering a new draft banking bill (the Banking Bill ) which, if passed into law in its current form, will: